US approval for Lyumjev

The FDA has approved Lilly’s Lyumjev rapid-acting mealtime insulin to reduce high blood sugar after meals and keep blood glucose levels in-range. This approval offers

Read More »

Covid-19 and hyperglycaemia link

New research indicates that nearly half of hospitalised Covid-19 patients without a prior diabetes diagnosis have hyperglycaemia – which is an independent predictor of mortality

Read More »

Film for thought

A new animated short film discusses the importance of diabetes classification. The video details the differences between Type 1 and Type 2 diabetes, in addition to

Read More »